As the technological spin-offs from the HGP become more prevalent, there are a variety of concerns about the way in which this technology will be incorporated into social life, particularly concerns about genetic discrimination. While the work associated with the HGP affirms that social rather than genetic explanations account for disparities in disease linked to [...]
health communication's tag archives
Development and Validation of Tools to Assess Genetic Discrimination: DISCUSSION
Development and Validation of Tools to Assess Genetic Discrimination: Results
In response to the first research question, a five-factor solution for the genetic discrimination instrument (GDI) emerged as the most parsimonious structure, including 20 items that accounted for 50.11% of the variance (Table 2). The five dimensions of genetic discrimination included: 1) a seven-item individual reproductive rights factor (M=2.21, SD=1.14; S2=26.47%, a=0.91); 2) three-item social [...]
Continue reading " Development and Validation of Tools to Assess Genetic Discrimination: Results "
Development and Validation of Tools to Assess Genetic Discrimination: METHOD
This research was conducted in three phases: 1) formative research, 2) pilot study and 3) instrument development. Formative Research Phase This phase of the study involved 15 focus groups conducted with 120 participants who had not previously undergone genetic testing and had little knowledge of human genetics as assessed by screening questions during recruitment. Focus [...]
Continue reading " Development and Validation of Tools to Assess Genetic Discrimination: METHOD "
Development and Validation of Tools to Assess Genetic Discrimination: PSYCHOLOGICAL DIMENSION
A long history of noncompliance in medicine supports the vital role played by health beliefs on health behavior. Current levels of adherence to drug regimens, for example, are low. An analysis of compliance rates reported in studies of heart disease as one illustration showed that only 31-66% of patients stayed in care, between 31-58% took [...]
Development and Validation of Tools to Assess Genetic Discrimination
An increasing number of public messages, including direct-to-consumer advertising for genetic testing and therapies, reference race as shorthand to capture scientific associations relating disease susceptibility and drug metabolism. Media theory and research suggest a wide variety of stereotyping effects arise from the use of racial exemplars to illustrate specific issues. Thus, public messages referencing race [...]
Continue reading " Development and Validation of Tools to Assess Genetic Discrimination "
More About The Site
Search
Categories
- Main (166)
- Drugs (38)
- Health (120)
- Cancer (39)
- Diseases (130)
- Depression (7)
- Men's Health (1)
- Swine Flu (3)
- HIV (16)
- Infectious diseases (1)
- Health Care (4)
- asthma (12)
- Diabetes (13)
- Blood Pressure (10)
- Weight Loss (8)
- Metabolism (5)
Advertisement
Tags
- accidents African Americans anxiety asthma Atrophia maculosa varioliformis cutis Canada Cancer CASR Chest Physiotherapy children children/adolescents Chronic Bronchitis Clinical Pharmacy Depression developing countries Diabetes disabilities documentation ethnicity Expiratory Pressure familial hyperparathyroidism FIHP functionality genetics hemodialysis HIV/AIDS HRPT2 incidence lodinated Glycerol Lymphoma MEN1 menin Mucolytic Study Obstructive Bronchitis osteoporosis parafi- bromin placebo-controlled study polymorphisms prevention prostate cancer road traffic injuries Scar traffic safety unintentional injuries vitamin D receptor
Archives
- January 2012 (14)
- December 2011 (17)
- August 2011 (1)
- July 2011 (4)
- May 2011 (16)
- April 2011 (30)
- March 2011 (31)
- February 2011 (28)
- January 2011 (21)
- December 2010 (30)
- November 2010 (12)
- September 2010 (2)































